TNFSF10 and diabetic ketoacidosis: In fact, it has previous been demonstrated that circulating levels of TRAIL significantly decrease in T1D, with the lowest levels of TRAIL being documented in T1D patients with diabetic ketoacidosis (DKA) and depending on the severity of the disease (10).